Today Jun 14, 2021
Event Image
Back to Events

An Overview of CLL and the Use of a Targeted Agent for Previously Untreated or R/R CLL

Wednesday Jul 07, 2021
Event Time 12:15 - 12:45 PM ET
Register Now
Faculty
Event Faculty

Nilanjan Ghosh, MD

Chief of Lymphoma Division
Levine Cancer Institute
New Hyde Park, NY

This program presents clinical efficacy and safety data supporting the use of a selective Bruton tyrosine kinase inhibitor for the treatment of previously untreated and R/R CLL 

Event Sponsors